These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 12007747)

  • 1. Clozapine and haloperidol reinstate latent inhibition following its disruption during amphetamine withdrawal.
    Russig H; Murphy CA; Feldon J
    Neuropsychopharmacology; 2002 Jun; 26(6):765-77. PubMed ID: 12007747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haloperidol and clozapine antagonise amphetamine-induced disruption of latent inhibition of conditioned taste aversion.
    Russig H; Kovacevic A; Murphy CA; Feldon J
    Psychopharmacology (Berl); 2003 Nov; 170(3):263-270. PubMed ID: 12898122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
    Gaisler-Salomon I; Weiner I
    Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haloperidol- and clozapine-induced enhancement of latent inhibition with extended conditioning: implications for the mechanism of action of neuroleptic drugs.
    Weiner I; Shadach E; Barkai R; Feldon J
    Neuropsychopharmacology; 1997 Jan; 16(1):42-50. PubMed ID: 8981387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The latent inhibition model of schizophrenia: further validation using the atypical neuroleptic, clozapine.
    Weiner I; Shadach E; Tarrasch R; Kidron R; Feldon J
    Biol Psychiatry; 1996 Nov; 40(9):834-43. PubMed ID: 8896769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards an animal model of an antipsychotic drug-resistant cognitive impairment in schizophrenia: scopolamine induces abnormally persistent latent inhibition, which can be reversed by cognitive enhancers but not by antipsychotic drugs.
    Barak S; Weiner I
    Int J Neuropsychopharmacol; 2009 Mar; 12(2):227-41. PubMed ID: 18687163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormally persistent latent inhibition induced by lesions to the nucleus accumbens core, basolateral amygdala and orbitofrontal cortex is reversed by clozapine but not by haloperidol.
    Schiller D; Zuckerman L; Weiner I
    J Psychiatr Res; 2006 Mar; 40(2):167-77. PubMed ID: 15882871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prepulse inhibition during withdrawal from an escalating dosage schedule of amphetamine.
    Russig H; Murphy CA; Feldon J
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):340-53. PubMed ID: 12428150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluctuation of latent inhibition along the estrous cycle in the rat: modeling the cyclicity of symptoms in schizophrenic women?
    Arad M; Weiner I
    Psychoneuroendocrinology; 2008 Nov; 33(10):1401-10. PubMed ID: 18819755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The latent inhibition model dissociates between clozapine, haloperidol, and ritanserin.
    Shadach E; Gaisler I; Schiller D; Weiner I
    Neuropsychopharmacology; 2000 Aug; 23(2):151-61. PubMed ID: 10882841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latent inhibition, but not prepulse inhibition, is reduced during withdrawal from an escalating dosage schedule of amphetamine.
    Murphy CA; Fend M; Russig H; Feldon J
    Behav Neurosci; 2001 Dec; 115(6):1247-56. PubMed ID: 11770056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine manipulations limited to preexposure are sufficient to modulate latent inhibition.
    Bethus I; Muscat R; Goodall G
    Behav Neurosci; 2006 Jun; 120(3):554-62. PubMed ID: 16768607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption and potentiation of latent inhibition by risperidone: the latent inhibition model of atypical antipsychotic action.
    Weiner I; Schiller D; Gaisler-Salomon I
    Neuropsychopharmacology; 2003 Mar; 28(3):499-509. PubMed ID: 12629529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of latent inhibition in the rat by the 5-HT2 agonist DOI: effects of MDL 100,907, clozapine, risperidone and haloperidol.
    Hitchcock JM; Lister S; Fischer TR; Wettstein JG
    Behav Brain Res; 1997 Oct; 88(1):43-9. PubMed ID: 9401707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A putative animal model of the "prodromal" state of schizophrenia.
    Tenn CC; Fletcher PJ; Kapur S
    Biol Psychiatry; 2005 Mar; 57(6):586-93. PubMed ID: 15780845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of microinjections of apomorphine and haloperidol into the inferior colliculus on the latent inhibition of the conditioned emotional response.
    Melo LL; Pereira EC; Pagini CH; Coimbra NC; Brandão ML; Ferrari EA
    Exp Neurol; 2009 Mar; 216(1):16-21. PubMed ID: 19084523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrasting effects of increased and decreased dopamine transmission on latent inhibition in ovariectomized rats and their modulation by 17beta-estradiol: an animal model of menopausal psychosis?
    Arad M; Weiner I
    Neuropsychopharmacology; 2010 Jun; 35(7):1570-82. PubMed ID: 20237462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scopolamine induces disruption of latent inhibition which is prevented by antipsychotic drugs and an acetylcholinesterase inhibitor.
    Barak S; Weiner I
    Neuropsychopharmacology; 2007 May; 32(5):989-99. PubMed ID: 16971898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia.
    Zuckerman L; Rehavi M; Nachman R; Weiner I
    Neuropsychopharmacology; 2003 Oct; 28(10):1778-89. PubMed ID: 12865897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of JL13, a pyridobenzoxazepine with potential atypical antipsychotic activity, in animal models for schizophrenia.
    Ellenbroek BA; Liégeois JF; Bruhwyler J; Cools AR
    J Pharmacol Exp Ther; 2001 Jul; 298(1):386-91. PubMed ID: 11408566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.